Life Saving Drugs Program resources – Infantile-onset LAL-D – Sebelipase alfa (Kanuma)

This collection contains guidelines, forms and documents related to accessing sebelipase alfa under the Life Saving Drugs Program.

Collection description

View the product information for Sebelipase alfa (Kanuma®)  on the Therapeutic Goods Administration website.



We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Date last updated:
Publication type:
Health sector

Help us improve

If you would like a response please use the enquiries form instead.